Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$59.95 - $92.06 $187,823 - $288,423
-3,133 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$81.07 - $121.29 $253,992 - $380,001
3,133 New
3,133 $279,000
Q3 2021

Oct 21, 2021

SELL
$101.99 - $166.36 $743,201 - $1.21 Million
-7,287 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$141.6 - $179.06 $178,132 - $225,257
1,258 Added 20.87%
7,287 $1.12 Million
Q1 2021

May 12, 2021

SELL
$132.81 - $182.18 $298,955 - $410,087
-2,251 Reduced 27.19%
6,029 $871,000
Q4 2020

Feb 04, 2021

BUY
$138.17 - $184.34 $895,341 - $1.19 Million
6,480 Added 360.0%
8,280 $1.41 Million
Q3 2020

Nov 02, 2020

BUY
$114.09 - $145.51 $205,362 - $261,917
1,800 New
1,800 $273,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.